ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item

May 2, 1980

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Blood Vessel Growth Inhibitor May Be Tested Against KS

August 16, 1991

Bosnian Research Trying To Leave, Asks For More Calls

February 5, 1993

DCPC Board Ok’s Grant Programs In Prevention, Public Education

October 30, 1992

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

September 20, 1991